INTRODUCTION
In the early reports on the administration of adrenocorticotropic hormone and cortisone to patients with various disease states, there were described a number of effects, the reproduction of which might conceivably alter the course of infections in man. Among these effects were defervescence, decrease in edema and inflammation, change in antibody production, and alteration in the state of hypersensitivity to bacterial products. Clinical evidence of such effects was provided by Finland, Kass and Ingbar (1) who showed that adrenocorticotropic hormone may effect striking alterations in the course of pneumococcal and primary atypical pneumonia. Moreover, equally striking changes were observed by Freeman and his coworkers in two patients with pulmonary tuberculosis (2). The modification of response to infection, by an agent which presumablv acts solely upon the host, thus presents an opportunity for further evaluation of the participation of host mechanisms in tuberculous disease.
There are relatively few forms of tuberculosis in humans appropriate for such a study. A serious form of progressive disease, with a reasonably predictable course, is necessary. It is desirable to avoid reliance upon chest roentgenograms as the sole means of evaluating changes in a tuberculous lesion. In this situation, the extent of viable tissue within a lesion must be determined by a procedure which is highly subjective before proper evaluation 1 Presented in part before The American Society for Clinical Investigation, Atlantic City, N. J., May 1, 1950. 2This study was supported in part by grants of subsequent changes within the lesion can be accomplished. Although the accuracy of the method is increased by having the roentgenograms interpreted independently by several competent observers, the interpretations frequently do not reflect the course of the disease as judged by other criteria (3). Such is not the case, however, when a lesion is available in which changes occurring after the introduction of a variable can be easily observed by more direct visualization. For these reasons, a special effort was made to include patients with active laryngeal tuberculosis in this study.
COMPOSITION OF CLINICAL SERIES AND METHODS OF STUDY
Seven patients with far advanced pulmonary tuberculosis were selected for study. Four of the seven had active laryngeal tuberculosis with lesions of the larynx which could be readily visualized by indirect laryngoscopy. A fifth patient had tuberculous empyema on the right side and was considered to be in a terminal phase of her illness. The strains of M. tuberculosis isolated in cultures of specimens of sputum from four of the seven patients were highly resistant to dihydrostreptomycin in vitro.
The course of tuberculous illness in each patient was evaluated prior to hormone administration from the available clinical, roentgenographic, bacteriologic and immunologic data. Whenever possible, a preliminary observation period of seven to ten days was undertaken. Each patient then received 100 mgm. of hormone intramuscularly in four equally divided doses at six hour intervals for an initial ten day period. Four of the patients received adrenocorticotropic hormone-4 and three received cortisone. 4 Throughout the study all patients were maintained at rest in bed. They received diets of their own selection and an estimate was made of actual caloric and protein intake. The pulse rate and rectal temperature were recorded at two hour intervals. In addition to customary bedside (6) and the concentration of serum gamma globulin by the method of Kunkel (7) . Bone marrow examinations with particular reference to the plasma cell count were done as described by Good and Campbell (8) In three of the four febrile patients defervescence was complete within six hours of the start of hormone administration (Figures 1-3 ). This process required 72 hours for completion in one patient ( Figure 4 ). All patients remained essentially afebrile until the cessation of hormone administration. Defervescence was accompanied by a feeling of increased strength and desire for physical activity. Appetite increased markedly with concurrent rise in the caloric and protein intake.
In the four patients with laryngitis improvement in phonation and disappearance of dysphagia were evident by the end of the initial 48 hour period of hormone administration. Thereafter, a progressive increase in the volume of the voice and improvement in its quality ensued. Discomfort from dyspnea and cough was markedly relieved although the volume of the sputum was not significantly decreased. All of the patients experienced some degree of a sense of well-being which in some amounted to euphoria.
The cessation of hormone administration was followed by abrupt return of the signs and symptoms of acute illness. The manifestations of acute illness immediately following the end of hormone administration were at least equal in severity to those present before hormone administration and Fever occurred within 18 hours after the last dose of adrenocorticotropic hormone. Following the cessation of cortisone administration, however, fever occurred on the second and sixth day (Figures 4 and 5 ) or was not a prominent feature in the post-hormone course ( Figure 6 ).
The fever following the end of hormone administration was self-limited in two patients who were essentially afebrile prior to hormone administration ( Figures 5 and 7) . In one patient (Figure 1 ) despite the institution of dihydrostreptomycin therapy soon after stopping adrenocorticotropic hormone, fever continued for four weeks. It may be noted here that in this patient, subsidence of fever coincided with the return of cutaneous hypersensitivity to tuberculoprotein. Significant defervescence was not observed during dihydrostreptomycin administration in another patient ( Figure 4 ). Subsequently, the strain of M. tuberculosis isolated from cultures of the sputum of this patient was found to be resistant in vitro to dihydrostreptomycin.
Laryngeal lesions: Observations of the changes in the laryngeal lesion was made by daily indirect laryngoscopic examination in the four patients with tuberculous laryngitis. In all patients a similar sequence of changes was observed. The changes noted in the laryngeal lesion of one patient (P. M.) are depicted in Figure 8 and may be considered as characteristic of the changes observed in all patients studied.
In this patient, initial examination of the left side of the larynx demonstrated ulceration with partial replacement by granulation tissue of the lateral portion of the arytenoid tubercle, aryepiglottic fold and true vocal cord, in addition to absence of one-half of the epiglottis. The entire right half of the larynx was edematous with marked inflammation and both true vocal cords were irregular.
Forty-eight hours after the beginning of hormone administration, edema and inflammation had subsided almost completely. In the ulcerated le- Figure 9 portraying enlarged segments of chest roentgenograms from one of the patients (P. M. hormone administration. Progressive decrease in the size and density of the roentgenographic appearance of the lung lesions ensued, marked clearing being noted seven months after hormone administration ( Figure 9 ).
Resorption of a small purulent intrapleural exudate was observed in one patient during the administration of adrenocorticotropic hormone. As this patient (S. H.) was in the terminal phase of her illness, prolonged observation after hormone administration was impossible. No well-defined changes in the roentgenographic appearance of the lung lesions occurred in two patients, one receiving adrenocorticotropic hormone (A. R.) and the other cortisone (J. M.).
Roentgenographic evidence of dissemination of the tuberculous process was not obtained in any patient.
Skin hypersensitivity to tuberculoprotein: Repeated observations on the skin hypersensitivity to tuberculoprotein were made. In each of the six patients tested an amount of tuberculin (Purified Protein Derivative) was used sufficient to elicit an unequivocally positive reaction prior to the administration of hormone. Reversal of cutaneous hypersensitivity to this individually standardized amount of tuberculoprotein was observed during hormone administration in three of the six patients tested. This reversal of a previously positive response was maintained for three to four weeks after the cessation of hormone administration in the two patients followed from this standpoint. In three patients (Figures 4, 6 and 7 ) negative reactions were not obtained.
It is of considerable interest that despite the continued absence of cutaneous hypersensitivity to the test dose of tuberculoprotein the acute manifestations of tuberculous illness reappeared following cessation of hormone administration in the three patients in whom reversal of the tuberculin skin test was obtained.
Serum gamma globulin and tuberculin hemagglutinating antibodies: The substantially elevated serum gamma globulin values initially present in one patient (Figure 7) Within three weeks after completion of hormone administration, however, three patients had significant increases both in the concentration of serum gamma globulin and in the titer of the tuberculin hemagglutinating antibodies (Figures 1,  2 and 6 ). The rises were sustained in one patient (P. M.) in whom the values reached a maximum between the 14th and 16th weeks and declined thereafter. Although significant increases in both serum components were noted in another patient (R. R.) immediately following cessation of cortisone administration, the evolution of the changes has been observed for only a short period of time. In the third patient (E. C.) reinstitution of adrenocorticotropic hormone at the peak of the rise in serum gamma globulin and hemagglutinating antibody titer was administration, in the ninth week of study, hallucinations and delusions appeared abruptly. The following week fever recurred with gradual return of malaise,;cough, and increasing prostration; cutaneous hypersensitivity to the test dose of tuberculoprotein also reappeared (Figure 2 ). The patient's condition rapidly became worse, despite continuation of adrenocorticotropic hormone and the addition of 100 mgm. per day of cortisone. Gradual reduction and cessation of adrenocorticotropic hormone administration failed to produce evidence of improvement. Cortisone administration was maintained for four days without apparent change in the patient's clinical condition and was discontinued in the fifth consecutive week of hormone administration. Thirty-six hours following cessation of cortisone administration, this patient expired.
Reinstitution of adrenocorticotropic hormone in another patient (Figure 3 ) was followed by a succession of events similar to those described above, although less pronounced. Marked symptomatic improvement and defervescence were gradually supplanted by euphoria and general weakness. Death occurred on the 21st consecutive day of hormone administration in the fifth week of study without recurrence of prostration or fever.
Post-mortem examination revealed no evidence of recent dissemination of the tuberculous process or significant alteration in the histopathology of the tuberculous process in either patient. The adrenal cortices of both patients were uniformly thickened and the glands were increased in weight. It is of interest that a small nodule of caseation necrosis was found at the surface of the right adrenal gland in one patient (S. H.).
Subsequent course: Two of the patients (P. M. and J. M.) have shown steady, favorable progress following the institution of dihydrostreptomycin and para-amino-salicylic acid administration. Sputum concentrates and cultures no longer show the presence of M. tubercuolsis. Marked clearing in the chest roentgenogram of P. M. has occurred as previously noted. The activity of his tuberculous process being considered arrested, J. M. has been discharged from the hospital.
ACTH AND CORTISONE IN TUBERCULOSIS
One of the patients (A. R.) whose sputum contained a strain of M. tuberculosis found to be resistant to dihydrostreptomycin in vitro, has been observed for ten months while receiving pneumoperitoneum therapy and bed rest. Her clinical status, though not conspicuously changed, has shown slight improvement. No significant alteration of her laryngeal lesion has been observed since the changes noted immediately after cessation of adrenocorticotropic hormone administration. terious effect of cortisone administration, however, has been noted during the four month period of observation.
Tubercle bacilli: Tubercle bacilli were discharged in the sputum of all patients without significant fluctuations in number throughout. the period of observation. Retention by the tubercle bacilli of initial staining properties with carbol fuchsin and Sudan black B and of initial in vitro sensitivity to dihydrostreptomycin was observed. Colonies grown on oleic acid-albumin attained the morphologic characteristics attributed to virulent organisms by Middlebrook, Dubos, and Pierce (5) in all specimens examined. Therefore, no bacteriologic evidence of alteration in the tubercle bacilli isolated from sputum or empyema was obtained.
COMMENT From the observations reported above, it appears that abrupt and profound changes in the course of tuberculous illness may be brought about by the introduction of hormones which presumably affect only the host.
During the period of administration of these hormones, rapid amelioration and subsequent disappearance of the constitutional manifestations of acute illness were witnessed. Complete defervescence was accompanied by a seemingly improved state wherein increase in strength, appetite, and desire for activity occurred. It is of particular interest to note that the onset of the seemingly improved state was equally evident in two patients (J. M. and A. R.) who were essentially afebrile prior to hormone administration. Imiiprovement in phonation and disappearance of dysphagia was striking as was the recession and subsequent quiescent appearance of the laryngeal lesions. Decrease in density of the lung lesions seen on chest roentgenogram was noted in five patients. Reversal of cutaneous hypersensitivity to an arbitrarily selected amount of tuberculoprotein was observed in three of the six patients tested.
The termination of the state of apparent improvement following the withdrawal of hormone administration was equally evident. The signs and symptoms of acute illness which had been alleviated, reappeared abruptly, and were equal to or even more severe than those present before hormone administration. mechanisms by which this infection produces fever and other manifestations of illness are not completely understood. It has been generally believed that the tissue damage and the clinical illness are, in large part, consequences of the interaction of previously sensitized tissue and the absorbed products from tubercle bacilli (9a). In vitro studies have been demonstrated that cells of the hypersensitive body are damaged and killed by amounts of tuberculoprotein that are harmless to cells in the absence of hypersensitivity (9b). Whether the living tubercle bacillus exerts a primary toxic effect upon host tissue is not definitely established (10) . Diminution in the manifestations of illness might be expected if, by alteration in the reactivity of host tissue, some degree of desensitization to the products of infection was obtained. Conversely, upon reappearance of the effects of hypersensitization their return would not be surprising.
From the observations reported here, it seems clear that reactivity of host tissues sufficient to cause severe symptoms of tuberculous illness may be present without the presence of a positive Mantoux test. Moreover, distinct symptomatic improvement was observed after the start of hormone therapy in those patients whose Mantoux test remained positive. The inability to utilize clinical quantitation and subsequent correlation of local and systemic tissue hypersensitivity to tuberculoprotein makes speculation on this aspect inadvisable.
The sudden suppression of the clinical evidence of toxicity observed to occur at the start of hormone administration may be compared to the similar state observed in patients with tuberculosis under treatment with streptomycin. Loss of socalled "toxemic" symptoms may occur in both situations and although improvement following the initiation of streptomycin therapy may be observed as early as the third day of therapy, it has not been observed to be as rapid in onset nor does its speed approach that of the changes occurring in the patients reported above. Thus the same phenomenon, sudden suppression of the clinical evidences of toxicity, may be produced on the one hand, by actions exerted principally upon the parasite and on the other, by action exerted solely through the host.
The course of the two patients who expired suggests that the changes effected by a fixed amount of adrenocorticotropic hormone are temporary and cannot be sustained, even with continued administration. Whether modification of the amount of hormone administered, alteration in the frequency of administration, or the combination with other agents will alter this situation is yet to be determined.
SUMMARY
The effects of adrenocorticotropic hormone and cortisone on the course of tuberculous illness has been studied in seven patients with far advanced pulmonary tuberculosis. It was found that abrupt and profound changes in the course of the illness were brought about by administration of these hormones. These changes were in the nature of defervescence, improvements in the sense of wellbeing, increased strength, improvement in appetite, as well as decrease in the edema and in the amount of exudate in the local lesions of the larynx. In all patients the improved state was temporary and, as might be anticipated, could not be indefinitely maintained by further administration of the hormones.
Observations were also made on the changes in cutaneous hypersensitivity to tuberculoprotein, in concentration of serum gamma globulin and in the titer of tuberculin hemagglutinating antibodies. Reversal of cutaneous hypersensitivity to an arbitrarily selected amount of tuberculoprotein during hormone administration was observed in three of the six patients tested. Within three weeks after completion of hormone administration significant increases both in concentration of serum gamma globulin and in the titer of tuberculin hemagglutinating antibodies were noted in three of the seven patients.
Interpretation of these temporary alterations in the disease state in terms of ultimate effect in such a chronic infection must await further study.
